Well just to be listed and trading again would be pretty euphoric in my book as that would reassure me some of the previous claims were going to come true...I'm sure may will sell right away just to $$$ in and want to invest else where after these delay shambles and who could blame them ! but if (sic) we do get to that stage then surely this will be just the start of better days ahead....?...thats my fantasy ...among many (the others I can mention on here ...ahem..;-)
Cambridge Cognition Holdings plc (Cambridge, UK - LSE: COG, 'Company'), the neuroscience digital health company, is pleased to announce it has been awarded £0.3m of R&D funding by the UK's innovation agency, Innovate UK, to develop a novel digital health system which will elicit and automatically analyse pain-related signals in human speech.
This pioneering new project will see Cambridge Cognition develop a digital health system for objective measurement of pain based on signals in a person's voice. It follows the Company successfully demonstrating the feasibility of automated verbal cognitive assessments on consumer voice platforms at the Alzheimer's Association International Conference in July 2017 as detailed in the Company announcement made on 7 June 2017.
if it does 'fly' on the right RNS even getting in on the 1st day trading will see you well (on a long term view), obviously being in before or at 8.30/9am that day (sell off dead cat bounce) would be even better..
just a word of warning for the naive or new investor on here, 29% or 50% 'up' don't mean sh*t with this AIM company ! no one ever calls the bottom of the market or the top for that matter. Until the expected RNS' to the market come out , even getting in at 1p will seem like small chips if the company realises its potential dreams,..
1\Is this DFM upgrade due to performance testing and feedback from key clients (due to have been completed over 18 months ago) 2\If not when if this ever going to happen as that means its even further behind than expected
While there is some good news here with today's RNS, this still gives us no real update on how close to commercialisation and sales the company is at in my view.